217
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Physicochemical Characterization of Diclofenac Sodium-Loaded Poloxamer Gel as a Rectal Delivery System with Fast Absorption

, , , , , , , , , & show all
Pages 545-553 | Published online: 05 Dec 2003

References

  • Choi H.G., Jung J.H., Ryu J.M., Yoon S.J., Oh Y.K., Kim C.K. Development of in-situ gelling and mucoadhesive acetaminophen liquid suppository. Int. J. Pharm. 1998; 165: 33–44
  • Huang C.H., Tokumura T., Machida Y., Nagai T. Formulation of double-layered suppository for prolonged stay in lower rectum. Yakuzaigaku 1987; 47: 42–48
  • Dumortier G., Zumer M., Courarraze G., Chaumeil J.C., Grossiord J.L. Rheological study of a thermoreversible morphine gel. Drug Dev. Ind. Pharm. 1991; 17: 1255–1265
  • Choi H.G., Kim M.H., Lee M.K., Kim C.K. Effect of additives on the physicochemical properties of liquid suppository. Int. J. Pharm. 1999; 190: 13–19
  • Yun M.O., Choi H.G., Jung J.H., Kim C.K. Development of thermoreversible insulin liquid suppository with sodium salicylate. Int. J. Pharm. 1999; 189: 137–145
  • Anderson B.D., Conradi R.A. Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J. Pharm. Sci. 1985; 74: 815–820
  • Iwata M., Takayama K., Takahashi Y., Obata Y., Machida Y., Nagai T., Shirotake S. Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories. Yakugaku Zasshi (Japan) 1999; 119: 170–177
  • Schneeweis A., Muller-Goymann C.C. In vivo and in vitro diclofenac sodium evaluation after rectal application of soft gelatine capsules enabling application induced transformation (AIT) into a semisolid system of liquid crystals (SSLC) for controlled release. Pharm. Res. 1997; 14: 1726–1729
  • Nakanishi K., Masukawa T., Masada M., Nadai T. Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository. Biol. Pharm. Bull. 1994; 17: 1496–1500
  • Ramakrishna S., Fadnavis N.W., Diwan P.V. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans. Arzneimittelforschung 1996; 46: 175–177
  • Miyazaki S., Nakamura T., Takada M. Thermo-sensitive sol–gel transition of Pluronic F-127. Yakuzaigaku 1991; 51: 36–43
  • Miyazaki S., Nakamura T., Yokouchi C., Tanaka M. Effect of pluronic gels on the rectal absoption of indomethacin in rabbits. Chem. Pharm. Bull. 1987; 35: 1243–1248
  • Miyazaki S., Suisha F., Kawasaki N., Shirakawa M., Yamatoya K., Attwood D. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J. Control. Rel. 1998; 56: 75–83
  • Garcia M.S., Albero M.I., Sanchez-Pedreno C., Molina J. Flow-injection spectrophotometric determination of diclofenac sodium in pharmaceuticals and urine samples. J. Pharm. Biomed. Anal. 1998; 17(2)267–273
  • Idkaidek N.M., Amidon G.L., Smith D.E., Najib N.M., Hassan M.M. Determination of the population pharmacokinetic parameters of sustained-release and enteric-coated oral formulations, and the suppository formulation of diclofenac sodium by simultaneous data fitting using NONMEM. Biopharm. Drug Dispos. 1998; 19(3)169–174
  • Pinto Pereira L.M., Chen D., Clement Y., Simeon D. Analgesic effects of diclofenac suppository and injection after preoperative administration. Int. J. Clin. Pharmacol. Res. 1999; 19(2)47–51
  • Choi H.G., Jung J.H., Yong C.S., Rhee J.D., Lee M.K., Han J.H., Park K.M., Kim C.K. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J. Control. Rel. 2000; 68: 405–412
  • Choi H.G., Kim C.K. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J. Control. Rel. 2000; 68: 397–404
  • Robinson S.S., Robinson J.R. Polymer structure features contributing to mucoadhesion. II. J. Control. Rel. 1990; 12: 187–194
  • Robert C.R., Buri P.A., Peppas N.A. Experimental method for bioadhesive testing of various polymers. Acta Pharm. Technol. 1988; 34: 95–98
  • Kramaric A., Resman A., Kofler B., Zmitek J. Thermoreversible Gel as a Liquid Pharmaceutical Carrier for a Galenic Formulation. European Patent. 0551 626 (A1), 1992

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.